Evaluation of two commercially available immunoassays for the detection of hantavirus antibodies in serum samples

Journal of Clinical Virology

Volumn 17, Issue 3, 2000, Pages 189-196

  Koraka, P ^a   Avsic Zupanc, T ^b   Osterhaus, A D M E ^a   Groen, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Diagnostics; Hantavirus; Serology

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; HANTAVIRUS; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS HEMORRHAGIC FEVER;

ANTIBODIES, VIRAL; COMPARATIVE STUDY; EVALUATION STUDIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMAN; IMMUNOENZYME TECHNIQUES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 0034283480     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(00)00096-2     Document Type: Article

References (23)

1. Avsic-Zupanc T., Toney A., Anderson K., Chu Y.K., Schmaljohn C. Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae. J. Gen. Virol. 76:1995;2801-2808.
2. Earl D.P. Symposium on epidemic haemorrhagic fever. Am. J. Med. 16:1954;617-709.
3. Elgh F., Wadell G., Juto P. Comparison of the kinetics of Puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescence test. J. Med. Virol. 45:1995;146-150.
4. Elgh F., Linderholm M., Wadell G., Juto P. The clinical usefulness of a Puumala recombinant nucleocapsid protein based enzyme-linked immunosorbent assay in the diagnosis of nephropathia epidemica as compared with an immunofluorescence assay. Clin. Diagn. Virol. 6:1996;17-26.
5. Groen J., Van der Groen G., Hoofd G., Osterhaus A.D.M.E. Comparison of immunofluorescence and enzyme-linked immunosorbent assays for the serology of Hantaan virus infection. J. Virol. Methods. 23:1989;195-203.
6. Groen J., Dalrymple J., Fisher-Hoch S., Jordans H.G.M., Clement J.P., Osterhaus A.D.M.E. Serum antibodies to structural proteins of hantavirus arise at different times after infection. J. Med. Virol. 37:1992;283-287.
7. Groen J., Gerding M.H., Jordans H.G.M., Clement J.P., Nieuwenhuijs J.H.M., Osterhaus A.D.M.E. Hantavirus infection in The Netherlands: epidemiology and disease. Epidemiol. Infect. 144:1995;373-383.
8. Hörling J., Lundkvist A., Persson K., Mullaart M., Dekonenko A., Tkachenko T., Niklasson B. Detection and subsequent sequencing of Puumala virus from human specimens by polymerase chain reaction. J. Clin. Microbiol. 33:1995;277-282.
9. Ivanov A., Vapalahti O., Lankinen H., Tkachenko E., Vaheri A., Niklasson B., Lundkvist A. Biotin-labeled antigen: a novel approach for detection of Puumala virus-specific IgM. J. Virol. Methods. 68:1996;3000-3006.
10. Kallio-Kokko H., Vapalahti O., Lundkvist A., Vaheri A. Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis. Clin. Diagn. Virol. 1/10:(1):1998;83-90.
11. Lee H.W., Lee P.W., Johnoson K.M. Isolation of the etiologic agent of Korean haemorrhagic fever from wild urban rats. J. Int. Med. 146:1978;638-644.
12. Lundkvist A., Hörling J., Niklasson B. The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays. Arch. Virol. 130:1993;121-130.
13. Mustonen J., Vapalahti O., Henttonen H., Pasternack A., Vaheri A. Epidemiology of hantavirus infections in Europe. Nephrol. Dial. Transplant. 13:1998;2729-2731.
14. Niklasson B., Tkachenko E., Ivanov A.P., van der Groen G., Wiger D., Andersen H.K., LeDuc J., Kjelsson T., Nystrom K. Haemorrhagic fever with renal syndrome: evaluation of ELISA for detection of Puumala-virus-specific IgG and IgM. Res. Virol. 141:(6):1990;637-648.
15. Plyusnin A., Hörling J., Kanerva M., Mustonen J., Cheng Y., Partanen J., Vapalahti O., Kukkonen S.K.J., Niemimaa J., Henttonen H., Niklasson B., Lundkvist A., Vaheri A. Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J. Clin. Microbiol. 35:1997;1090-1096.
16. Schmaljohn C.S., Suriyama K., Schmaljohn A.L., Bishop D.H. Baculovirus expression of the small genome segment of Hantaan virus and potential use of the expressed nucleocapsid protein as a diagnostic antigen. J. Gen. Virol. 69:1988;777-786.
17. Schmaljohn C., Hjelle B. Hantavirus: a global disease problem. Emerg. Infect. Dis. 3:(2):1997;95-104.
18. Sjölander K.B., Elgh F., Kallio-Kokko H., Vapalahti O., Hagglund M., Palmcrantz V., Juto P., Vaheri A., Niklasson B., Lundkvist A. Evaluation of serological methods for diagnosis of Puumala Hantavirus infection (nephropathia epidemica). J. Clin. Microbiol. 35:(12):1997;3264-3268.
19. Sjölander K.B., Lundkvist A. Dobrava virus infection: serological diagnosis and cross-reactions to other hantaviruses. J. Virol. Methods. 80:(2):1999;137-143.
20. Vapalahti O., Lundkvist A., Kallio-Kokko H., Paukku K., Julkunen I., Lankinen H., Vaheri A. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J. Clin. Microbiol. 34:1996;119-125.
21. World Health Organization (WHO). Report of a meeting on Hantavirus vaccine development. WHO/EMC/95.2, WHO, 1995.
22. Zöller L., Yang S., Gött P., Bautz E.K., Darai G. Use of recombinant nucleocapsid proteins of the Hantaan and nephropathia epidemica serotypes of hantaviruses as immunodiagnostic antigens. J. Med. Virol. 39:1993;200-207.
23. Zwieg M.H., Robertson E.A. Clinical validation of immunoassays: a well designed approach to a clinical study. Can D.W., Perstein M.T. Immunoassay, A Practical Guide. 1987;97-127 Academic Press, Orlando, FL.